Login to Your Account

Axl, Mer Kinases: Not All Bad, Study Says

By Anette Breindl
Science Editor

Friday, July 26, 2013
Axl and Mer are oncogenic receptor tyrosine kinases. That much is clear. "They transform cells, and they play a role in migration, invasion and metastasis," Sourav Ghosh told BioWorld Today. As a result, several companies are developing inhibitors of Axl and Mer, including Rigel Pharmaceuticals Inc. and Bergenbio A/S.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription